Dapagliflozin Beneficial for Improving MASH Without Worsening Fibrosis

FRIDAY, June 6, 2025 (HealthDay News) -- For patients with metabolic dysfunction-associated steatohepatitis (MASH), treatment with dapagliflozin is beneficial f